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Introduction
Nosocomial infections are induced in hospitalized pa-
tients. These patients do not have these infections at the 
time of reference, but are infected at the time of hospi-
talization (1). Nosocomial infections are caused two days 
after hospitalization or discharge from the hospital (2). 
Despite the efforts and measures to control nosocomial 
infections, economic costs and mortality, are high (3). 
Nosocomial infections are the sixth cause of death in the 
United States with 9900 fatalities per annum approxi-
mately (4). Klebsiella pneumoniae is the most important 
cause of nosocomial infections among gram-negative 
bacteria (5). K. pneumoniae is an opportunistic pathogen 
in hospitals, which causes the most common nosocomial 
infections, such as urinary tract, pneumonia, septicemia, 
wound, and bloodstream (5). K. pneumoniae is gram-neg-
ative, rod-shaped, aerobic and facultative anaerobic, non-
motile, nitrate positive, with mucoid colonies, and large 
polysaccharide capsule (6). Four species of the genus Kleb-
siella include K. pneumoniae, K. rhinoscleromatis, K. ozae-
nae, and K. oxytoca that were introduced as pathogens to 
human (7,8). K. granulomatis (called Calymmatobacteri-
um granulomatis) also is a human pathogen that is almost 
unknown (8). Klebsiella species, according to the bio-
chemical reactions, can be distinguished from one anoth-
er (7). One of the major challenges about K. pneumoniae 
is emerging strains resistant to antibiotics (9). Overuse of 
antibiotics has caused a lot of resistance in the bacteria (9). 
Approximately 21 000 resistance genes have been identi-
fied in bacteria (10). Today, the relationships between the 
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Abstract
Introduction: Klebsiella pneumoniae is one of Klebsiella species. K. pneumoniae is one 
of the most important bacteria causing nosocomial infections. This bacterium threatens 
public health and leads to increased hospital costs and mortality rate. The purpose of 
this study was to determine the pattern of antibiotic resistance in K. pneumoniae in 
nosocomial infections.
Methods: This study was performed on 51 samples of Klebsiella isolates from 500 patients 
in three units of Aleshtar hospital in 9 months. The antibiotic resistance of K. pneumoniae 
to 18 antibiotics was performed by Kirby Bauer disk diffusion method.
Results: The frequency of K. pneumonia among 500 samples was determined 51 cases 
(10.2%). The largest number of K. pneumoniae was isolated from the infectious unit 
(49.02%). The frequency of K. pneumoniae based on the source of infection for urine 
was 22 cases (43.14%), sputum 17 (33.33%), stool 6 (11.77%), wound 4 (7.84%), blood 
2 (3.92%), and cerebrospinal fluid 0 (0%), respectively. K. pneumoniae resistance to 
antibiotics included: ceftriaxone (94.12%), ciprofloxacin (90.20%), ofloxacin (86.27%), 
cefotaxime (78.43%), nalidixic acid (58.82%), nitrofurantoin (56.86%), aztreonam 
(54.90%), ampicillin/sulbactam (50.98% ), ticarcillin (45.09%), cefepime (43.14%), colistin 
(43.14%), gentamicin (41.18%), azithromycin (41.18%), polymyxin B (39.22%), piperacillin/
tazobactam (19.61%), amikacin ( 15.69%), imipenem (5.88%), and meropenem (3.92%).
Conclusion: Meropenem and imipenem with the lowest resistance were the most 
effective antibiotics against K .pneumoniae. Ceftriaxone, and ciprofloxacin antibiotic had 
the lowest effect on the treatment of K. pneumoniae.
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uses of antibiotics for treatment and antibiotic resistance 
in K. pneumoniae is very clear (10). In 1983, a wide range 
of extended-spectrum beta-lactamases (ESBLs) for resis-
tance to cephalosporins were reported in Klebsiella strains 
(11). After that, the use of third generation of cephalospo-
rins, such as ceftriaxone, cefotaxime and ceftazidime has 
been limited to the treatment of infections caused by K. 
pneumoniae (11). In recent years, multi-drug resistance 
(MDR) in K. pneumoniae has been observed around the 
world (12). K. pneumoniae carbapenemases (KPC) is re-
sistant to carbapenem, amino glycosides, cephalosporins, 
and fluoroquinolones, which usually is sensitive to the 
colistin antibiotic (12). Indiscriminate use of colistin has 
led to several resistance cases in K. pneumoniae (12). KPC 
is the most prominent Enterobacteriaceae for the produc-
tion of the enzyme (12). The purpose of this study was 
to determine the pattern of antibiotic resistance in K. 
pneumoniae by the Kirby Bauer Disk Diffusion (KBDD) 
method. In this study, the most effective antibiotic to treat 
K. pneumoniae infections has been identified.
Methods
This study was performed on 500 clinical specimens iso-
lated from hospitalized patients in Aleshtar (Lorestan 
province) in 2014. Urine, stool, blood, sputum, wound, 
and cerebrospinal fluid (CSF) samples were collected from 
critical care unit (CCU), infectious, and surgery units at 
the hospital. Samples were cultured on blood agar (Mer-
ck), and Macconkey agar (Merck) media and were incu-
bated at 37°C for 24 hours. Suspected colonies to Klebsiella 
were maintained by the scrutiny of culture media. Klebsi-
ella samples were isolated by urease, Simmons citrate, ar-
ginine decarboxylase, triple sugar-iron (TSI), and sulfur-
indole-motility (SIM) biochemical tests. To identify the 
Klebsiella species were used from Methyl Red/Voges Pros-
kauer (MR/VP), urease, malonate, and SIM differential 
biochemical tests. Four pathogen Klebsiella species were 
identified from each other by these tests. Each sample was 
cultured in a different media and K. pneumoviae species 
were isolated after incubation. In order to determine the 
pattern of antibiotic resistance of K. pneumoniae, disk 
diffusion method was performed. In this case, after the 
preparation of bacterial suspension turbidity of 0.5 Mc-
Farland standard, each sample was cultured on Mueller 
Hinton agar (Himedia) medium. Then 18 antibiotic disks 
were placed on the Plates. These included: piperacillin/
tazobactam (100/10 μg), ampicillin/sulbactam (10/10 μg), 
ticarcillin (75 μg), ceftriaxone (30 μg), cefotaxime (75 μg), 
ciprofloxacin (5 μg), ofloxacin (5 μg), cefepime (30 μg), 
colistin (10 μg), amikacin (30 μg), gentamicin (10 μg), 
imipenem (10 μg), meropenem (10 μg), nitrofurantoin 
(300 μg), polymyxin B (300 units), azithromycin (15 μg), 
nalidixic acid (30 μg) and aztreonam (30 μg). Plates were 
incubated for 24 hours at 37°C. All antibiotic disks were 
prepared from MAST group. Finally, halos diameter cre-
ated around each disk were measured based on Clinical 
Laboratory standards Institute (CLSI 2014) by a ruler and 
were recorded as resistant (R) intermediate (I), and sus-
ceptible (S). SPSS version 20 software was used for data 
analysis.
Results
Of 500 samples collected from nosocomial infections, 
52 samples (10.4%) were for the genus Klebsiella, which 
51 cases (10.2%) were related to K. pneumoniae species. 
From the 51 samples of K. pneumoniae, 35 (68.63%) were 
for females and 16 (31.37%) for males. P-Value for gender 
was significant (0.02) and it showed that Klebsiella infec-
tions were related to the gender. The highest number of 
frequency for K. pneumoniae at the hospital units was re-
lated to infectious, surgery, and CCU (Table 1). Accord-
ing to the source of infection, most of K. pneumoniae was 
isolated from urine, sputum, stool, and blood samples, 
respectively (Table 2). Of the total samples, 52 cases con-
tained Klebsiella. Of this number, 51 samples were for K. 
pneumoniae, and 1 case was related to K. oxytoca (Table 3).
The highest rate of antibiotic resistance with 48 cases 
(94.12%) was related to ceftriaxone and the lowest was re-
lated to 2 cases (3.92%) of meropenem. The number of K. 
pneumoniae of resistant, intermediate, and susceptible are 
specified to 18 antibiotics tested in Table 4.
Table 1. The frequency of K. pneumoniae in hospital units
Hospital Unit Number %
Infectious 25 49.02
Surgery 18 35.29
CCU 8 15.69
Total 51 100
CCU, critical care unit
Table 2. The number of K. pneumoniae in sites of infection
Site of Infection Number %
Urine 22 43.14
Sputum 17 33.33
Stool 6 11.77
Wound 4 7.84
Blood 2 3.92
CSF 0 0.00
Total 51 100
CSF, cerebrospinal fluid
Table 3. The frequency of K. pneumoniae among Klebsiella species
Klebsiella Spp. Number %
K. pneumoniae 51 98.08
K. oxytoca 1 1.92
K. rhinoscleromatis 0 0.00
K. ozaenae 0 0.00
Total 52 100
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Discussion
K. pneumoniae is one of the most common bacteria that 
causes infections in patients (13). Choosing the best an-
tibiotic is very important for the treatment of nosocomial 
infections caused by K. pneumoniae. The use of ineffec-
tive antibiotics is the cause of the spread of antibiotic re-
sistance in Klebsiella species. In this study, of 500 isolates 
from nosocomial infections, 51 cases (10.2%) were related 
to K. pneumoniae. This shows the high prevalence of this 
pathogen in infections. Based on the results obtained in 
this study, K. pneumoniae antibiotic resistance is high. The 
use of ceftriaxone, ciprofloxacin, and ofloxacin antibiotics 
for the treatment of infections caused by K. pneumoniae 
not only helps the treatment, but also it causes antibiotic 
resistance. This study revealed that meropenem, and imi-
penem are the most effective antibiotics for K. pneumoni-
ae. Of 52 isolates of Klebsiella, just one sample was related 
to K. oxytoca. This indicates that K. pneumoniae is the 
most common Klebsiella species in nosocomial infections. 
Studies worldwide have determined the frequency of K. 
pneumoniae in nosocomial infection. In a study by Bina 
et al (14) in 2015, in order to determine K. pneumoniae 
carbapenemase in clinical samples, it was shown that the 
most antibiotic resistance was for piperacillin (60.6%) 
and the least resistance was for imipenem (13.9%). In this 
study, more than 14% of K. pneumoniae strains were resis-
tant to carbapenem (14).
Barakzahi et al (15) have specified the antibiotic resistance 
of K. pneumoniae at the hospital of Zahedan in 2014. In this 
study, the highest numbers of K. pneumoniae were isolated 
from urine and the lowest number from CSF. They also 
reported that most of antibiotic resistance of K. pneumoni-
ae was related to cefixime (82%), and cefotaxime (81%) 
(15). A study by Feizabadi et al (16) was performed on 
the antibiotic resistance of K. pneumoniae in two hospitals 
in Tehran in 2007. The highest antibiotic resistance of K. 
pneumoniae was reported for amoxicillin-clavulanic acid 
(81.81%) and aztreonam (78.78%), and the least resistance 
was for piperacillin/tazobactam (15.15%) (16). Manjula 
et al (17) reported that the prevalence of K. pneumoniae 
in urinary tract infections in women was about 10% in 
southwest India. In this study, the antibiotic resistance of 
K. pneumoniae was determined by Kirby-Bauer disk dif-
fusion. They reported the most K. pneumoniae resistance 
against ampicillin, nitrofurantoin, and cefuroxime.
In a study by Kumar (18) has been determined the an-
tibiotic susceptibility of K. pneumoniae isolated from the 
pus. In this study, of 198 samples, the prevalence of K. 
pneumoniae was 21.1%, and the lowest antibiotic resis-
tance was related to amikacin (11.9%) (18). Kalaskar and 
Venkataramana (19) have reported K. pneumoniae resis-
tance to cephalosporins 1-4 generations close to 100% in 
2012. In this study, most of K. pneumoniae was isolated 
from urine (19). Romanus and Egwu (20) examined the 
antibiotic susceptibility of K. pneumoniae in Nigeria in 
2011. In this study, in contrast to our study, K. pneumoniae 
sensitivity to all antibiotics was almost 100% (20). Table 5 
shows the comparison of K. pneumoniae resistance of the 
present study with other studies.
Conclusion
Antibiotic resistance is worrying in bacteria, and K. pneu-
moniae through the world has become a threat to public 
health. According to studies conducted in recent years, 
Table 4. The number of K. pneumoniae of resistant, intermediate, and susceptible to 18 antibiotics
Name Disk No. of Resistant (%) No. of Intermediate (%) No. of Susceptible (%)
Ceftriaxone 48 (94.12) 2 (3.92) 1 (1.96)
Ciprofloxacin 46 (90.20) 2 (3.92) 3 (5.88)
Ofloxacin 44 (86.27) 1 (1.96) 6 (11.77)
Cefotaxime 40 (78.43) 3 (5.88) 8 (15.69)
Nalidixic Acid 30 (58.82) 8 (15.69) 13 (25.49)
Nitrofurantoin 29 (56.86) 1 (1.96) 21 (41.18)
Aztreonam 28 (54.90) 4 (7.84) 19 (37.26)
Ampicillin/sulbactam 26 (50.98) 7 (13.73) 18 (35.29)
Ticarcilin 23 (45.09) 6 (11.77) 22 (43.14)
Cefepime 22 (43.14) 9 (17.65) 20 (39.21)
Colistin 22 (43.14) - 29 (56.86)
Gentamicin 21 (41.18) 10 (19.61) 20 (39.21)
Azithromycin 21 (41.18) 3 (5.88) 27 (52.94)
Polymyxin B 20 (39.21) - 31 (60.79)
Piperacillin/tazobactam 10 (19.61) 4 (7.84) 37 (72.55)
Amikacin 8 (15.69) 5 (9.80) 38 (74.51)
Imipenem 3 (5.88) 4 (7.84) 44 (86.27)
Meropenem 2 (3.92) 1 (1.96) 48 (94.12)
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K. pneumoniae resistance is spread to most antibiotics. In 
these conditions, Klebsiella antibiotic resistance should be 
determined by tests. This attempt can help to treat Klebsi-
ella infections and reduce mortality rate. Although, resis-
tance to multiple antibiotics especially in cases of nosoco-
mial organisms is not new, but it has in creased in recent 
years. The frequency of resistance to other classes of anti-
biotics such as quinolones and aminoglycosides are also 
high. Therefore, in the treatment of patients with these 
multidrug resistance organisms other options including 
combination therapy or potentially toxic drugs such as 
polymixin may be used.
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